GE HealthCare is a leading global medical technology and digital solutions innovator, dedicated to providing integrated solutions that enhance hospital efficiency, clinician effectiveness, and patient health. Their extensive portfolio includes advanced imaging technologies such as computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, and molecular imaging, along with patient monitoring systems and digital health solutions. Committed to precision care, GE HealthCare invests approximately $1 billion annually in research and development, ensuring continuous innovation. With a worldwide presence, the company serves healthcare providers across various regions, addressing diverse medical needs.
Fetal pulse oximetry technology aims to provide real-time insights to clinicians during labor and delivery and improve the detection of fetal distress.
SIGNA Sprint, a new wide bore 1.5T MRI scanner, is designed to provide power previously unattainable at 1.5T, for clarity in cardiology and oncology imaging.
At the ESTRO 2025 Congress, the company will showcase innovations designed to optimize the oncology care workflow and enable improved patient outcomes.
Cardiovascular disease, projected to cause 23M+ deaths by 2030, is driving a 175% surge in cardiac CT scans as a key diagnostic and monitoring tool worldwide.
Invenia ABUS Premium features new integrated Verisound AI and AI Assistant, which ensure faster and reproducible scanning and reading with extraordinary image quality.
A new cloud-suite of enterprise imaging solutions, the Genesis portfolio, is designed to help improve patient care coordination, reduce operational costs, and maintain robust security standards.
Freelium, a helium-free sealed magnet platform in development, aims to dramatically reduce liquid helium usage without sacrificing power efficiency, operational security and clinical performance.